Since the pandemic hit almost the entire world, specialists everywhere are looking for solutions. We are working on a vaccine, but at the same time we are testing possible treatments that could treat the disease.
It’s been about a year since the new type of virus appeared in China. It may be even more, if you take into account the fact that the official information there comes hard and almost always is incomplete, intentionally or not. In the meantime, efforts are being made to develop a vaccine, but the best treatments are also being sought.
Researchers in the UK, for example, are testing the theory that the most common drug could actually treat Covid-19.
It’s about aspirin.
Aspirin, tested as a possible treatment for Covid-19
In a clinical trial in the UK, aspirin will be evaluated as a possible treatment for COVID-19. Specialists want to know if this drug could reduce the risk of blood clots in people diagnosed with this disease.
It is known that aspirin has the property of thinning the blood. So British specialists start from this premise in their study.
“There is a clear rationale for believing that aspirin could be beneficial, and it is safe, inexpensive, and widely available,” said Peter Horby, a researcher in the clinical trial.
He points out that patients infected with the new coronavirus have a higher risk of forming blood clots due to hyper-reactive platelets (platelets), cells that play an important role in blood clotting and stopping bleeding. Aspirin is an antiplatelet agent and can reduce the risk of clots, according to a clinical study called RECOVERY.
What is the experiment in Britain?
The experiment is simple: at least 2,000 patients will randomly receive 150 milligrams of aspirin daily, along with regular treatment. Data from these patients will be compared with those from at least 2,000 other subjects receiving standard COVID-19 treatment.
Due to its blood-thinning properties, aspirin increases the risk of internal bleeding, and an overdose over an extended period of time has been associated with kidney damage, Reuters notes. Other treatments tested in the RECOVERY clinical trial include the common antibiotic azithromycin and the synthetic antibody cocktail from Regeneron, which was used to treat COVID-19 symptoms of US President Donald Trump.
And aspirin, if studies have good results, has another advantage. Unlike Remdesivir, for example, aspirin is a generic medicine, which means that it is a much cheaper treatment.